The Women and Infants Center and its physicians, nurses and staff have passed numerous milestones and garnered honors with patient care as the key focus.
Published in Service to Community
Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
Published in Focus on Patient Care
HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.
Published in Focus on Patient Care
Partridge was honored for his exceptional talents and his commitment to make progress towards finishing the fight against cancer.
Published in Focus on Patient Care

Alvarez's work in ovarian cancer research honored.

UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.

Published in Focus on Patient Care

Cancer researcher honored for outstanding care to cancer patients.

Published in Faculty Excellence
April 19, 2012

Alvarez, Ronald

Professor and director, UAB Division of Gynecological Oncology

Areas of expertise: gynecological cancers, cancer prevention

Published in Experts

UAB researcher presented several gynecological oncology studies to a national gathering of doctors.

Published in Focus on Patient Care
UAB researcher explores use of antibody mechanism in platelet production that may reduce ovarian cancer progression.
Published in Focus on Patient Care
April 15, 2011

Huh, Warner

Associate professor of gynecologic oncology and associate scientist in the UAB Comprehensive Cancer Center

Areas of expertise: Gynecologic oncology, cancer vaccine, robotic surgery for gyn/onc

Published in Experts

A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.

Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.
Back to Top